Stock Information
symbol line chart

NXPLNextPlat Corp

Upcoming Earnings

We were not able to find an announced earnings date for this symbol yet. Check back again later

Company Info

CEO

Charles M. Fernandez

Location

Florida, USA

Exchange

Nasdaq

Website

https://nextplat.com

Summary

NextPlat Corp provides mobile satellite services (MSS) solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and Internet of Things (IoT) connectivity services.

Company Info

CEO

Charles M. Fernandez

Location

Florida, USA

Exchange

Nasdaq

Website

https://nextplat.com

Summary

NextPlat Corp provides mobile satellite services (MSS) solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and Internet of Things (IoT) connectivity services.

AI Insights for NXPL
5 min read

Quick Summary

NextPlat Corp is a Nasdaq-listed micro-cap company that historically provides mobile satellite services and satellite-enabled communications products for voice, data, messaging, GPS location tracking, machine-to-machine connectivity, and Internet of Things applications. Its satellite communications offerings are designed for users who need connectivity in remote or mobile environments where traditional terrestrial networks may be unavailable or unreliable. The company also describes products such as SolarTrack, a solar-powered IoT tracking device intended for outdoor asset monitoring and movement tracking. In addition to communications technology, recent company-related news indicates that NextPlat is expanding healthcare operations through PharmcoRx and related digital-health-oriented initiatives. Its main customers can include remote workers, logistics and asset-tracking users, enterprise customers needing satellite connectivity, pharmacy patients, healthcare providers, 340B entities, long-term care organizations, and digital health users seeking prescription and telehealth access.

Strengths

•

NextPlat’s primary strength is its exposure to specialized markets where connectivity, remote monitoring, pharmacy access, and digital health services can solve practical customer problems.

•

The company has existing revenue and gross profit, which gives it more substance than a purely pre-revenue speculative issuer.

•

Its satellite communications and IoT products give it a technology-oriented foundation in remote connectivity and asset tracking.

•

Its healthcare expansion through PharmcoRx gives it access to pharmacy services, 340B opportunities, long-term care markets, and potentially recurring patient-service revenue.

•

Management’s willingness to add experienced healthcare leaders and upgrade systems suggests an effort to professionalize operations and improve execution.

Key Risks

•

NextPlat faces substantial execution risk because it is attempting to grow in competitive markets while still reporting losses.

•

The company’s healthcare expansion depends on regulatory compliance, reimbursement dynamics, pharmacy operations, payer relationships, and the ability to win and retain contracts.

•

Any failure in pharmacy compliance, patient data protection, prescription fulfillment quality, or healthcare licensing could harm reputation and financial performance.

•

The satellite communications market is also competitive and may be affected by rapid technology change, pricing pressure, supply constraints, and the dominance of larger network operators.

What to Watch

During the most recent reported period, NextPlat’s available fundamentals showed revenue of about $11.9 million, total gross profit of about $4.7 million, operating income of negative $127,000, and net income of negative $144,000.
The company remained unprofitable on an EPS basis, with negative basic EPS and negative diluted EPS, which likely kept attention on cost control and margin improvement.
A key company event was the expansion of healthcare operations to support higher-value patient services, including 340B and long-term care markets.
NextPlat appointed Birute Norkute as Vice President of Healthcare Operations and Alexis Fernandez as Director of Pharmacy, signaling an effort to strengthen operational leadership at PharmcoRx.
The company also said it was hiring sales and marketing professionals and upgrading software and systems to improve internal efficiency, customer service, responsiveness, and long-term profitability.

Price Drivers

•

NXPL’s stock price is likely driven by micro-cap sentiment, revenue growth expectations, operating losses, liquidity, healthcare expansion announcements, and investor appetite for speculative technology and healthcare names.

•

The company reported operating revenue of about $11.9 million, gross profit of about $4.7 million, and negative operating income, so investors may focus closely on whether management can turn gross profit into sustainable operating earnings.

•

Valuation metrics such as a market capitalization of roughly $24.7 million, price-to-book value near 1.51, and EV-to-revenue around 0.28 suggest the market may be discounting execution risk despite revenue generation.

•

The very wide 52-week range, from $4.34 to $111, and beta near 1.94 indicate that the stock can be highly volatile and sensitive to news, liquidity, and risk-on or risk-off market conditions.

•

Announcements related to PharmcoRx growth, 340B contracts, long-term care contracts, telehealth, pharmacy licensing, e-prescriptions, or satellite IoT customer wins could materially influence investor perception because the company is small and news flow can have an outsized impact.

Recent News

•

Recent news associated with NextPlat highlighted the company’s expansion of healthcare operations to pursue higher-value patient services, including 340B and long-term care markets.

•

The company appointed Birute Norkute as Vice President of Healthcare Operations, citing her experience in building Progressive Care and PharmcoRx into a significant independent pharmacy services provider in Florida.

•

It also named Alexis Fernandez as Director of Pharmacy, bringing more than 20 years of clinical and administrative pharmacy experience.

•

NextPlat said it is adding sales and marketing staff and upgrading software systems to improve profitability, operations, responsiveness, customer service, and patient care.

•

Other recent healthcare-related news in the feed discussed nationwide pharmacy licensure by Invictus Pharmacy and nationwide e-script certification for Australia-based NextClinic, reinforcing the broader digital pharmacy and telehealth themes surrounding the company’s news environment.

Market Trends

•

Several broader market trends affect NextPlat, including the growth of satellite IoT, demand for resilient remote communications, expansion of digital pharmacy, and rising adoption of telehealth services.

•

Remote monitoring and asset-tracking markets are benefiting from logistics modernization, industrial IoT deployment, and the need to manage equipment or personnel outside reliable cellular networks.

•

At the same time, healthcare is moving toward digital prescriptions, mail-order pharmacy, patient portals, virtual consultations, and integrated data systems.

•

The 340B and long-term care pharmacy markets can offer attractive opportunities, but they are also highly regulated and operationally demanding.

•

Micro-cap stocks are additionally influenced by interest rates, liquidity conditions, speculative trading appetite, and investor tolerance for companies that are growing but not yet consistently profitable.

AI-generated summary for educational purposes only. Not investment advice. Always do your own research before investing.

Community Research

Research from investors like you

Be the first to share your analysis on NXPL

Help fellow investors make informed decisions by sharing your research on fundamentals, catalysts, and outlook.

Topics: Company overview • Products • Competitors • Strengths & Risks

Symbol's posts

No more topics to show